peppersite
Bioregulatororal

Cartalax

Peptide bioregulator referenced for connective tissue support.

Researched for
Recovery
Not yet audited

We have not published an audit on Cartalax. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.

How it is thought to work

Tissue-specific peptide bioregulation (theoretical).

Cartalax is a tiny three-amino-acid peptide that researchers think may influence how cartilage cells behave and how certain genes are switched on or off, but this has only been shown in lab cell cultures, not in people.

Reported side effects

No Cartalax-specific side effects have been documented, but as with any unapproved peptide, there are general risks such as immune reactions, contamination, and inconsistent product quality.

Who should avoid it

People who are pregnant, breastfeeding, have cancer, autoimmune disease, serious kidney or liver problems, weakened immune systems, upcoming surgery, chronic infections, or who take multiple medications should talk to a doctor before considering Cartalax, because its safety in these situations is unknown.

Sources

The reference sections above are imported from our compound knowledge base, which classes the evidence for Cartalax as theoretical. That classification is the knowledge base’s, not ours, our own grade appears only where an audit is linked above. Research use only; nothing here is medical advice or a protocol.

Studied for the same things